Advice
following an abbreviated submission
brinzolamide / brimonidine tartrate eye drops, suspension (Simbrinza®) is accepted for use within NHS Scotland.
Indication under review: decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
There is no significant additional cost associated with the combination product compared with the individual components and it allows patients to administer fewer drops.
Download detailed advice111KB (PDF)
Medicine details
- Medicine name:
- brinzolamide and brimonidine (Simbrinza)
- SMC ID:
- 991/14
- Indication:
- Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
- Pharmaceutical company
- Alcon Eye Care UK Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 10 November 2014